PD 175069
PD 175069 is a potent and selective N-type calcium channel antagonist with an IC50 of 0.32 μM. PD 175069 is efficacious in an audiogenic seizure model using DBA/2 mice. PD 175069 can be used for research on neurological conditions such as neuropathic pain and stroke[1].
Product Specifications
CAS Number
217170-95-1
UNSPSC
12352005
Target
Calcium Channel
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Smiles
CC(C)CCN(C)[C@@H](CC(C)C)C(N[C@H](C(NC(C)(C)C)=O)CC1=CC=C(OCC2=CC=CC=C2)C=C1)=O
Molecular Formula
C32H49N3O3
Molecular Weight
523.75
References & Citations
[1]Hu LY, et al. Synthesis and biological evaluation of substituted 4- (OBz) phenylalanine derivatives as novel N-type calcium channel blockers. Bioorg Med Chem Lett. 1999 Apr 19;9 (8) :1121-6.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
N-type calcium channel
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LH16316V 100 µg
CLACP (COL25A1) (NM_198721) Human Over-expression Lysate
Sign In for Pricing
View Details 
